Degenerative Disc R&D Heats Up: Biorthex Evaluates Cervical Fusion Device
This article was originally published in The Gray Sheet
Executive Summary
Biorthex' recent IDE for the Actipore ACF places the Montreal-based firm with Medtronic and Synthes-Stratec in developing cervical implant approvals for the U.S. market
You may also be interested in...
Artificial Lumbar Disc Trial Results Could Make SpineCore Acquisition Target
SpineCore will begin a randomized, multi-site U.S. clinical trial for its FlexiCore intervertebral disc this month under a July 25 FDA investigational device exemption
Biorthex Anticipating Fourth-Quarter Roll-Out Of SpineCor Scoliosis Brace
Biorthex is planning a fourth-quarter U.S. launch of its SpineCor scoliosis brace, pending 510(k) clearance by FDA. Priced at approximately $1,000, the device will be positioned as an alternative and less restrictive treatment for early idiopathic scoliosis.
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.